 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, October 15, 1999, 19(20):8778-8788
Comparing Astrocytic Cell Lines that Are Inhibitory or Permissive for Axon Growth: the Major Axon-Inhibitory Proteoglycan Is NG2
Penny S. Fidler1, Katrin Schuette2, Richard A. Asher1, Alexandre Dobbertin2, Suzanne R. Thornton3, Yolanda Calle-Patino3, Elizabeth Muir1, Joel M. Levine4, Herbert M. Geller3, John H. Rogers1, Andreas Faissner2, 5, and James W. Fawcett1 1 Department of Physiology and Medical Research Council, Cambridge Centre for Brain Repair, University of Cambridge, Cambridge CB2 3EG, United Kingdom, 2 Department of Neurobiology, University of Heidelberg, 69120 Heidelberg, Germany, 3 Department of Pharmacology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, 4 Department of Neurobiology and Behavior, State University of New York, Stony Brook, New York, 11794, and 5 Laboratoire de Neurobiologie du Développement et de la Régénération (LNDR, UPR 1352), Centre de Neurochimie du Centre National de la Recherche Scientifique, F-67084 Strasbourg Cedex, France
Astrocytes, oligodendrocytes, and oligodendrocyte/type 2 astrocyte progenitors (O2A cells) can all produce molecules that inhibit axon regeneration. We have shown previously that inhibition of axon growth by astrocytes involves proteoglycans. To identify inhibitory mechanisms, we created astrocyte cell lines that are permissive or nonpermissive and showed that nonpermissive cells produce inhibitory chondroitin sulfate proteoglycans (CS-PGs). We have now tested these cell lines for the production and inhibitory function of known large CS-PGs. The most inhibitory line, Neu7, produces three CS-PGs in much greater amounts than the other cell lines: NG2, versican, and the CS-56 antigen. The contribution of NG2 to inhibition by the cells was tested using a function-blocking antibody. This allowed increased growth of dorsal root ganglion (DRG) axons over Neu7 cells and matrix and greatly increased the proportion of cortical axons able to cross from permissive A7 cells onto inhibitory Neu7 cells; CS-56 antibody had a similar effect. Inhibitory fractions of conditioned medium contained NG2 coupled to CS glycosaminoglycan chains, whereas noninhibitory fractions contained NG2 without CS chains. Enzyme preparations that facilitated axon growth in Neu7 cultures were shown to either degrade the NG2 core protein or remove CS chains. Versican is present as patches on Neu7 monolayers, but DRG axons do not avoid these patches. Therefore, NG2 appears to be the major axon-inhibitory factor made by Neu7 astrocytes. In the CNS, NG2 is expressed by O2A cells, which react rapidly after injury to produce a dense NG2-rich network, and by some reactive astrocytes. Our results suggest that NG2 may be a major obstacle to axon regeneration.
Key words: axon regeneration; chondroitin sulfate; NG2; extracellular matrix; proteoglycans; versican
Copyright © 1999 Society for Neuroscience 0270-6474/99/19208778-11$05.00/0
This article has been cited by other articles:
T. L. Laabs, H. Wang, Y. Katagiri, T. McCann, J. W. Fawcett, and H. M. Geller
Inhibiting Glycosaminoglycan Chain Polymerization Decreases the Inhibitory Activity of Astrocyte-Derived Chondroitin Sulfate Proteoglycans
J. Neurosci., December 26, 2007; 27(52): 14494 - 14501.
[Abstract] [Full Text] [PDF]
J. Chen, J. Wu, I. Apostolova, M. Skup, A. Irintchev, S. Kugler, and M. Schachner
Adeno-associated virus-mediated L1 expression promotes functional recovery after spinal cord injury
Brain, April 1, 2007; 130(4): 954 - 969.
[Abstract] [Full Text] [PDF]
A. von Holst, U. Egbers, A. Prochiantz, and A. Faissner
Neural Stem/Progenitor Cells Express 20 Tenascin C Isoforms That Are Differentially Regulated by Pax6
J. Biol. Chem., March 23, 2007; 282(12): 9172 - 9181.
[Abstract] [Full Text] [PDF]
Z. Yang, R. Suzuki, S. B. Daniels, C. B. Brunquell, C. J. Sala, and A. Nishiyama
NG2 glial cells provide a favorable substrate for growing axons.
J. Neurosci., April 5, 2006; 26(14): 3829 - 3839.
[Abstract] [Full Text] [PDF]
S. Neumann, K. Skinner, and A. I. Basbaum
Sustaining intrinsic growth capacity of adult neurons promotes spinal cord regeneration
PNAS, November 15, 2005; 102(46): 16848 - 16852.
[Abstract] [Full Text] [PDF]
N. Sanai, A. Alvarez-Buylla, and M. S. Berger
Neural Stem Cells and the Origin of Gliomas
N. Engl. J. Med., August 25, 2005; 353(8): 811 - 822.
[Full Text] [PDF]
Y. Wu, W. Sheng, L. Chen, H. Dong, V. Lee, F. Lu, C. S. Wong, W.-Y. Lu, and B. B. Yang
Versican V1 Isoform Induces Neuronal Differentiation and Promotes Neurite Outgrowth
Mol. Biol. Cell, May 1, 2004; 15(5): 2093 - 2104.
[Abstract] [Full Text] [PDF]
P. H. Larsen, J. E. Wells, W. B. Stallcup, G. Opdenakker, and V. W. Yong
Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan
J. Neurosci., December 3, 2003; 23(35): 11127 - 11135.
[Abstract] [Full Text] [PDF]
L. L. Jones, D. Sajed, and M. H. Tuszynski
Axonal Regeneration through Regions of Chondroitin Sulfate Proteoglycan Deposition after Spinal Cord Injury: A Balance of Permissiveness and Inhibition
J. Neurosci., October 15, 2003; 23(28): 9276 - 9288.
[Abstract] [Full Text] [PDF]
Y. Zhang, K. Arner, B. Ehinger, and M.-T. R. Perez
Limitation of Anatomical Integration between Subretinal Transplants and the Host Retina
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 324 - 331.
[Abstract] [Full Text] [PDF]
Y. M. Ughrin, Z. J. Chen, and J. M. Levine
Multiple Regions of the NG2 Proteoglycan Inhibit Neurite Growth and Induce Growth Cone Collapse
J. Neurosci., January 1, 2003; 23(1): 175 - 186.
[Abstract] [Full Text] [PDF]
A. A. Vyas, H. V. Patel, S. E. Fromholt, M. Heffer-Lauc, K. A. Vyas, J. Dang, M. Schachner, and R. L. Schnaar
From the Cover: Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration
PNAS, June 11, 2002; 99(12): 8412 - 8417.
[Abstract] [Full Text] [PDF]
R. L. Isaacson
Unsolved mysteries: the hippocampus.
Behav Cogn Neurosci Rev, June 1, 2002; 1(2): 87 - 107.
[Abstract] [PDF]
L. L. Jones, Y. Yamaguchi, W. B. Stallcup, and M. H. Tuszynski
NG2 Is a Major Chondroitin Sulfate Proteoglycan Produced after Spinal Cord Injury and Is Expressed by Macrophages and Oligodendrocyte Progenitors
J. Neurosci., April 1, 2002; 22(7): 2792 - 2803.
[Abstract] [Full Text] [PDF]
R. A. Asher, D. A. Morgenstern, M. C. Shearer, K. H. Adcock, P. Pesheva, and J. W. Fawcett
Versican Is Upregulated in CNS Injury and Is a Product of Oligodendrocyte Lineage Cells
J. Neurosci., March 15, 2002; 22(6): 2225 - 2236.
[Abstract] [Full Text] [PDF]
C. G. Becker and T. Becker
Repellent Guidance of Regenerating Optic Axons by Chondroitin Sulfate Glycosaminoglycans in Zebrafish
J. Neurosci., February 1, 2002; 22(3): 842 - 853.
[Abstract] [Full Text] [PDF]
S. Martin, A. K. Levine, Z. J. Chen, Y. Ughrin, and J. M. Levine
Deposition of the NG2 Proteoglycan at Nodes of Ranvier in the Peripheral Nervous System
J. Neurosci., October 15, 2001; 21(20): 8119 - 8128.
[Abstract] [Full Text] [PDF]
C. A. Krekoski, D. Neubauer, J. Zuo, and D. Muir
Axonal Regeneration into Acellular Nerve Grafts Is Enhanced by Degradation of Chondroitin Sulfate Proteoglycan
J. Neurosci., August 15, 2001; 21(16): 6206 - 6213.
[Abstract] [Full Text] [PDF]
E. A. Maher, F. B. Furnari, R. M. Bachoo, D. H. Rowitch, D. N. Louis, W. K. Cavenee, and R. A. DePinho
Malignant glioma: genetics and biology of a grave matter
Genes & Dev., June 1, 2001; 15(11): 1311 - 1333.
[Full Text] [PDF]
R. A. Asher, D. A. Morgenstern, P. S. Fidler, K. H. Adcock, A. Oohira, J. E. Braistead, J. M. Levine, R. U. Margolis, J. H. Rogers, and J. W. Fawcett
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
J. Neurosci., April 1, 2000; 20(7): 2427 - 2438.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|